| Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 15.63 mm | 15.63 mm | 15.63 mm | 15.63 mm | 15.63 mm | 15.63 mm |
| Cash burn (monthly) | 1.20 mm | 303.17 k | 4.92 mm | 5.13 mm | 1.12 mm | 947.92 k |
| Cash used (since last report) | 20.56 mm | 5.18 mm | 84.12 mm | 87.69 mm | 19.17 mm | 16.19 mm |
| Cash remaining | -4.93 mm | 10.45 mm | -68.48 mm | -72.06 mm | -3.53 mm | -560.07 k |
| Runway (months of cash) | -4.1 | 34.5 | -13.9 | -14.0 | -3.1 | -0.6 |
| 13F holders | Current |
|---|---|
| Total holders | 3 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 69.33 mm |
| Total shares | 20.55 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Flynn James E | 16.55 mm | $64.39 mm |
| Clarus Lifesciences I | 2.73 mm | $0.00 |
| Integrated Core Strategies | 1.27 mm | $4.94 mm |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Nov 23 | Van Hove Caroline F. | Common Stock | Payment of exercise | Dispose F | No | No | 0.71 | 741 | 526.11 | 8,239 |
| 13 Nov 23 | Ronald Menezes | Common Stock | Payment of exercise | Dispose F | No | No | 0.71 | 3,625 | 2.57 k | 16,775 |
| 7 Sep 23 | Oliver Christian Bennett | Common Stock | Grant | Acquire A | No | No | 1.75 | 2,739 | 4.79 k | 23,100 |
